the examination of questions related to the pharmacovigilance of medicinal products authorised by the Member States, in accordance with Articles 107c, 107e, 107g, 107k and 107q;
vastavalt artiklitele 107c, 107e, 107 g, 107k ja 107q uurida liikmesriikides müügiloa saanud ravimite ohutuse järelevalve küsimusi;